Open AccessSitagliptin Versus Ipragliflozin for Type 2 Diabetes in Clinical Practice
Author(s) -
Ikuro Matsuba,
Kotaro Iemitsu,
Takehiro Kawata,
Takashi Iizuka,
Masahiro Takihata,
Masahiko Takai,
Shigeru Nakajima,
Nobuaki Minami,
Shinichi Umezawa,
Akira Kanamori,
Hiroshi Takeda,
Shogo Ito,
Taisuke Kikuchi,
Hikaru Amemiya,
Mizuki Kaneshiro,
Atsuko Mokubo,
Tetsuro Takuma,
Hideo Machimura,
Keiji Tanaka,
Taro Asakura,
Akira Kubota,
Sachio Aoyagi,
Kazuhiko Hoshino,
Masashi Ishikawa,
Mitsuo Obana,
Nobuo Sasai,
Hideaki Kaneshige,
Masaaki Miyakawa,
Yasushi Tanaka,
Yasuo Terauchi
Publication year - 2019
Publication title -
journal of endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.184
H-Index - 3
eISSN - 1923-287X
pISSN - 1923-2861
DOI - 10.14740/jem604
Subject(s) - sitagliptin , medicine , type 2 diabetes , glycemic , blood pressure , renal function , diabetes mellitus , dipeptidyl peptidase 4 , gastroenterology , body mass index , dipeptidyl peptidase 4 inhibitor , endocrinology , urology , pharmacology